Skip to content
★ Sign in to follow
吴

吴以芳

Board Director
Director
复星医药
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€30k
▼ Sales (0 ops.)
—

Latest filing published 13 Sept 2022 for 复星医药, €30k.

Filing timeline

BuySale
吴以芳

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 13 Sept 2022 · 1519 days ago · €30k
    -16.6%
    Entry CN¥33.76 · Close at T+365 CN¥28.16

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

吴以芳: trading record in brief

Our data holds just one disclosure by 吴以芳, dated 13 September 2022, reporting an open-market purchase worth €30k in 复星医药. Further filings will be added here. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Companies and markets linked to 吴以芳

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    董事Executives复星医药
    207,720 CNY27SSE
    6,000 shares100.0% of flowA股XSHGSSE:173000005883199000
    Canonical exit: 12 Dec 2022 (T+90)

1 of 1 declaration